RE:RE:RE:Someone buying Canntrust?Daredevil1964 wrote: I would have to say that TRST is losing 150K to 200K per day plus the 13000kgs pulled off the selves. That is 13000x1000 grams x 5 dollars is 65 million is lost sales. It also seems to cost about 3 dollars a gram production costs which is 39 million dollars. So TRST lost the sale of 65 million and had production costs of 39 million for a total of 104 million. With 140 million shares outstanding that nearly shaves off a dollar a share. There is no telling how long Health Canada will take to review Canntrusts submissions due July 18. I am sure that Health Canada will inspect the sites as well. I think that this would be worth pursuing to purchase, but, it would have to be a fire sale price. A transfer or resubmission for licensing could take a while. One would think that the customer base would be worth something, if the customer's can be retained to the purchaser. I would think that there is a lot of tire kicking and there will be low ball offers. However, that being said, this would be a chance for a global to get in cheap. I would think that this may ruin Canntrust. Many of the offers would be for pennies on the dollar. As a day trading play, the volitility is there to make a few dollars, but it is a complete gamble. Not worth the risk when HC can close the doors anytime now.
APHA has enough capacity once DD comes on line to supply those 72000 patients. If TRST licenses is a suspension for 1-2 years and not a total revoke. TRST is doing $17M per quarter in revs. Lets say $70M a year. APHA should offer 4x revenue for TRST and run with it.